<DOC>
	<DOCNO>NCT01253174</DOCNO>
	<brief_summary>The purpose study examine compare uptake Yasmin ( oral contraceptive contain drospirenone ethinylestradiol ) without levomefolate calcium ( Metafolin , register vitamin supplement ) body examine compare uptake levomefolate calcium without Yasmin body , healthy volunteer use hormonal contraception .</brief_summary>
	<brief_title>Investigation Bioequivalence Ethinylestradiol ( EE ) Drospirenone ( DRSP ) Two Different Tablet Formulations : Yasmin Yasmin + Levomefolate Calcium ( Metafolin ) &amp; L-5-MTHF Two Different Tablet Formulations : Levomefolate Calcium ( Metafolin ) Yasmin + Levomefolate Calcium ( Metafolin )</brief_title>
	<detailed_description />
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Drospirenone ethinyl estradiol combination</mesh_term>
	<criteria>Healthy female volunteer Age : 18 38 year inclusive Body mass index ( BMI ) 1 : ≥ 19 &lt; 28 kg/m² Regular cyclic menstrual period screen OR use combined oral contraceptive recruitment period report natural cyclic menstrual period prior use Willingness use nonhormonal method contraception complete trial OR previous tubal ligation incompletely cure preexisting disease assume absorption , distribution , metabolism , excretion effect study drug normal know suspected sexsteroid influence malignancy endometrial hyperplasia ; genital bleed unknown origin ; uterus myomatosus know suspected tumor liver pituitary presence history severe hepatic disease long liver function value return normal severe renal insufficiency acute renal failure thrombophlebitis , venous / arterial thromboembolic disease ; presence history prodromi thrombosis condition increase susceptibility thromboembolic disease know neuropsychiatric disease , especially know suspected epilepsy , and/ deficient status folate vitamin B12 use medication within 2 cycle first study drug administration could affect study aim use potassium spar drug ; use folic acid contain supplement medicine use medication within 2 cycle first study drug administration know interfere folate metabolism inadequate folate and/or Vitamin B12 status , clinically relevant deviation red cell folate concentration</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>